| Identification | Back Directory | [Name]
Vildagliptin IMpurity 2 (Mixture of DiastereoMers) | [CAS]
1036959-23-5 | [Synonyms]
Vildagliptin Imp.M
Vigliptin Impurity B
Viglistine Impurity B
Vildagliptin IMpurity 2
Vildagliptin IMPURITY B
Vildagliptin Impurity 1
Vildagliptin imp D (Dimer)
Vildagliptin Dimer Impurity
Vidalettin impurity 2(diastereomer mixture)
Vildagliptin IMpurity 2 (Mixture of DiastereoMers)
(2S,2'S)-1,1'-(2,2'-((3-hydroxyadamantan-1-yl)azanediyl)bis(acetyl))bis(pyrrolidine-2-carbonitrile)
(2S,2'S)-1,1'-(2,2'-(((1r,5R,7S)-3-hydroxyadamantan-1-yl)azanediyl)bis(acetyl))bis(pyrrolidine-2-carbonitrile)
(2S,2'S)-1,1'-(2,2'-(((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)azanediyl)bis(acetyl))bis(pyrrolidine-2-carbonitrile)
(2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis-2-pyrrolidinecarbonitrile
(2S)-1-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]-(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
2-Pyrrolidinecarbonitrile, 1,1'-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis-, (2S,2'S)-
(2S)-1-{[{2[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}[(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)amino]]acetyl}pyrrolidine-2-carbonitrile
Vildagliptin Impurity 6/Vildagliptin Dimer Impurity/(2S,2S)-1,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis[2-Pyrrolidinecarbonitrile] | [Molecular Formula]
C24H33N5O3 | [MDL Number]
MFCD34471971 | [MOL File]
1036959-23-5.mol | [Molecular Weight]
439.55 |
| Chemical Properties | Back Directory | [Melting point ]
>177°C | [Boiling point ]
730.0±60.0 °C(Predicted) | [density ]
1.33±0.1 g/cm3(Predicted) | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
14.99±0.40(Predicted) | [color ]
Pale Yellow |
| Questions And Answer | Back Directory | [Uses]
(2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis-2-pyrrolidinecarbonitrile is an impurity of Vildagliptin which is an oral anti-hyperglycemic agent that inhibit dipeptidyl peptidase 4 (DPP-4). |
|
|